Acacetin and chrysin, two polyphenolic compounds, alleviate telomeric position effect in human cells

Molecular Therapy Nucleic Acids

Volumn 2, Issue AUG, 2013, Pages e116-

  Boussouar, Amina ^a   Barette, Caroline ^b   Nadon, Robert ^c   Saint Léger, Adelaïde ^a,d   Broucqsault, Natacha ^e   Ottaviani, Alexandre ^a,d   Firozhoussen, Arva ^a   Lu, Yiming ^f   Lafanechère, Laurence ^g   Gilson, Eric ^a,d,h   Magdinier, Frédérique ^a,e   Ye, Jing ^a,d,f  

^a UNIVERSITÉ DE LYON   (France)

^b CEA GRENOBLE   (France)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF NICE SOPHIA ANTIPOLIS   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

^f SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^g INSERM   (France)

^h CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

DNA damage response; Flavanoid; Polyphenol; Telomere; Telomere induced foci; Telomeric position effect

Indexed keywords

ACACETIN; CHRYSIN;

ARTICLE; CELL PROLIFERATION; CHROMOSOME; CONTROLLED STUDY; DNA DAMAGE; DNA DAMAGE CHECKPOINT; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; HUMAN; HUMAN CELL; POSITION EFFECT; PRIORITY JOURNAL; TELOMERE; UPREGULATION;

EID: 84884239064     PISSN: None     EISSN: 21622531     Source Type: Journal    
DOI: 10.1038/mtna.2013.42     Document Type: Article

References (35)

1. Blackburn, EH, Greider, CW and Szostak, JW (2006). Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med 12: 1133-1138. (Pubitemid 44527346)
2. de Lange, T (2005). Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 19: 2100-2110. (Pubitemid 41330312)
3. Giraud-Panis, MJ, Pisano, S, Poulet, A, Le Du, MH and Gilson, E (2010). Structural identity of telomeric complexes. FEBS Lett 584: 3785-3799.
4. Blackburn, EH (2000). The end of the (DNA) line. Nat Struct Biol 7: 847-850.
5. Buseman, CM, Wright, WE and Shay, JW (2012). Is telomerase a viable target in cancer? Mutat Res 730: 90-97.
6. Deng, Y, Chan, SS and Chang, S (2008). Telomere dysfunction and tumour suppression: the senescence connection. Nat Rev Cancer 8: 450-458. (Pubitemid 351744962)
7. Rudolph, KL, Millard, M, Bosenberg, MW and DePinho, RA (2001). Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat Genet 28: 155-159. (Pubitemid 32538061)
8. Ségal-Bendirdjian, E and Gilson, E (2008). Telomeres and telomerase: from basic research to clinical applications. Biochimie 90: 1-4. (Pubitemid 350216221)
9. Ye, J, Wu, Y and Gilson, E (2010). Dynamics of telomeric chromatin at the crossroads of aging and cancer. Essays Biochem 48: 147-164.
10. Biroccio, A, Rizzo, A, Elli, R, Koering, CE, Belleville, A, Benassi, B et al. (2006). TRF2 inhibition triggers apoptosis and reduces tumourigenicity of human melanoma cells. Eur J Cancer 42: 1881-1888. (Pubitemid 44149082)
11. Salvati, E, Leonetti, C, Rizzo, A, Scarsella, M, Mottolese, M, Galati, R et al. (2007). Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect. J Clin Invest 117: 3236-3247. (Pubitemid 350096981)
12. Simonet, T, Zaragosi, LE, Philippe, C, Lebrigand, K, Schouteden, C, Augereau, A et al. (2011). The human TTAGGG repeat factors 1 and 2 bind to a subset of interstitial telomeric sequences and satellite repeats. Cell Res 21: 1028-1038.
13. Yang, D, Xiong, Y, Kim, H, He, Q, Li, Y, Chen, R et al. (2011). Human telomeric proteins occupy selective interstitial sites. Cell Res 21: 1013-1027.
14. Baur, JA, Zou, Y, Shay, JW and Wright, WE (2001). Telomere position effect in human cells. Science 292: 2075-2077. (Pubitemid 32691573)
15. Koering, CE, Pollice, A, Zibella, MP, Bauwens, S, Puisieux, A, Brunori, M et al. (2002). Human telomeric position effect is determined by chromosomal context and telomeric chromatin integrity. EMBO Rep 3: 1055-1061. (Pubitemid 35469897)
16. Ottaviani, A, Gilson, E and Magdinier, F (2008). Telomeric position effect: from the yeast paradigm to human pathologies? Biochimie 90: 93-107. (Pubitemid 350216211)
17. Pedram, M, Sprung, CN, Gao, Q, Lo, AW, Reynolds, GE and Murnane, JP (2006). Telomere position effect and silencing of transgenes near telomeres in the mouse. Mol Cell Biol 26: 1865-1878.
18. Zhang, JH, Chung, TD and Oldenburg, KR (1999). A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen 4: 67-73. (Pubitemid 29278954)
19. Wermuth, CG (2004). Selective optimization of side activities: another way for drug discovery. J Med Chem 47: 1303-1314. (Pubitemid 38327456)
20. Malo, N, Hanley, JA, Carlile, G, Liu, J, Pelletier, J, Thomas, D et al. (2010). Experimental design and statistical methods for improved hit detection in high-throughput screening. J Biomol Screen 15: 990-1000.
21. Ottaviani, A, Rival-Gervier, S, Boussouar, A, Foerster, AM, Rondier, D, Sacconi, S et al. (2009). The D4Z4 macrosatellite repeat acts as a CTCF and A-type lamins-dependent insulator in facio-scapulo-humeral dystrophy. PLoS Genet 5: e1000394.
22. Pan, MH, Lai, CS, Wang, YJ and Ho, CT (2006). Acacetin suppressed LPS-induced up-expression of iNOS and COX-2 in murine macrophages and TPA-induced tumor promotion in mice. Biochem Pharmacol 72: 1293-1303.
23. Wu, HJ, Sun, HY, Wu, W, Zhang, YH, Qin, GW and Li, GR (2013). Properties and molecular determinants of the natural flavone acacetin for blocking hKv4.3 channels. PLoS ONE 8: e57864.
24. Ning, Y, Xu, JF, Li, Y, Chavez, L, Riethman, HC, Lansdorp, PM et al. (2003). Telomere length and the expression of natural telomeric genes in human fibroblasts. Hum Mol Genet 12: 1329-1336. (Pubitemid 36722613)
25. Gabellini, D, Green, MR and Tupler, R (2002). Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell 110: 339-348.
26. Rijkers, T, Deidda, G, van Koningsbruggen, S, van Geel, M, Lemmers, RJ, van Deutekom, JC et al. (2004). FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients. J Med Genet 41: 826-836. (Pubitemid 39524309)
27. Sfeir, A, Kosiyatrakul, ST, Hockemeyer, D, MacRae, SL, Karlseder, J, Schildkraut, CL et al. (2009). Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell 138: 90-103.
28. Martínez, P, Thanasoula, M, Muñoz, P, Liao, C, Tejera, A, McNees, C et al. (2009). Increased telomere fragility and fusions resulting from TRF1 deficiency lead to degenerative pathologies and increased cancer in mice. Genes Dev 23: 2060-2075.
29. Ye, J, Lenain, C, Bauwens, S, Rizzo, A, Saint-Léger, A, Poulet, A et al. (2010). TRF2 and apollo cooperate with topoisomerase 2alpha to protect human telomeres from replicative damage. Cell 142: 230-242.
30. Woodman, OL and Chan, ECh (2004). Vascular and anti-oxidant actions of flavonols and flavones. Clin Exp Pharmacol Physiol 31: 786-790. (Pubitemid 39556854)
31. Boege, F, Straub, T, Kehr, A, Boesenberg, C, Christiansen, K, Andersen, A et al. (1996). Selected novel flavones inhibit the DNA binding or the DNA religation step of eukaryotic topoisomerase I. J Biol Chem 271: 2262-2270. (Pubitemid 26051584)
32. Bajgai, SP, Prachyawarakorn, V, Mahidol, C, Ruchirawat, S and Kittakoop, P (2011). Hybrid flavan-chalcones, aromatase and lipoxygenase inhibitors, from Desmos cochinchinensis. Phytochemistry 72: 2062-2067.
33. Jaganathan, SK and Mandal, M (2009). Antiproliferative effects of honey and of its polyphenols: a review. J Biomed Biotechnol 2009: 830616.
34. Liu, LZ, Jing, Y, Jiang, LL, Jiang, XE, Jiang, Y, Rojanasakul, Y et al. (2011). Acacetin inhibits VEGF expression, tumor angiogenesis and growth through AKT/HIF-1a pathway. Biochem Biophys Res Commun 413: 299-305.
35. Ottaviani, A, Schluth-Bolard, C, Rival-Gervier, S, Boussouar, A, Rondier, D, Foerster, AM et al. (2009). Identification of a perinuclear positioning element in human subtelomeres that requires A-type lamins and CTCF. EMBO J 28: 2428-2436